IGM Financial (TSE:IGM – Get Free Report) had its price target raised by investment analysts at BMO Capital Markets from C$47.00 to C$48.00 in a research report issued on Monday,BayStreet.CA reports.

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

BMO Capital Markets maintained its Market Perform rating on Terreno Realty Corporation (NYSE:TRNO) but increased the price target from $71.00 to $73.00. The adjustment follows Terreno Realty's ...

Wednesday's consumer-price index for January looms in the minds of bond-market participants, as investors and traders also remain focused on the prospect of trade wars between the U.S. and other ...

"This was a decent fourth quarter GDP print that highlighted rock-solid consumer spending and a sustainable economic ...

O’Reilly Automotive (NASDAQ:ORLY – Free Report) had its price target lifted by BMO Capital Markets from $1,400.00 to ...

U.S. government debt was little changed overnight and into Monday morning, despite President Donald Trump's intention to impose 25% tariffs on all steel and alum ...

BMO Capital downgraded Q32 Bio (QTTB) to Market Perform from Outperform with a price target of $3, down from $22. The company announced an ...

BMO Capital Markets downgraded Everest Group to Market Perform due to deeper underwriting issues and a $1.7B reserve charge, ...

As well as hitting $1 billion in quarterly revenue for the first time, Pinterest reached record user numbers, with 553 ...